Toshiba America Medical Systems Inc.’s latest dose reduction software, Adaptive Iterative Dose Reduction (ADIR) 3D, has received FDA clearance, the company announced.

The third generation software, which Toshiba will offer to existing Aquilion One, Premium, and Prime CT customers, reduces radiation dose compared to conventional scanning, the company said. The algorithm, designed to work in raw data and imaging data space, reduces noise while attempting to maintain image quality.

The ADIR 3D can be integrated with Sure Exposure 3D, software that calculates the minimum radiation exposure required for every exam based on pre-set targeted level of image quality.

 CT modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of CT across the healthcare continuum, from various cancer screenings, such as lung and colon, to cardiothoracic imaging, to appendicitis, and more.

Adaptive Iterative Dose Reduction (ADIR) 3D, the third generation software, will be offered to existing Aquilion One, Premium, and Prime CT customers.

FDA Clears Toshiba’s Latest Dose Reduction Software